Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Nirosha Suraweera, Dmitri Mouradov, Shan Li, Robert N. Jorissen, Debbie Hampson, Anil Ghosh, Neel Sengupta, Mohamed Thaha, Shafi Ahmed, Michael Kirwan, Floor Aleva, David Propper, Roger M. Feakins, Tom Vulliamy, Ngaire J. Elwood, Pei Tian, Robyn L. Ward, Nicholas J. Hawkins, Zheng-Zhou Xu, Peter L. Molloy, Ian T. Jones, Matthew Croxford, Peter Gibbs, Andrew Silver, Oliver M. Sieber
Published Apr 26, 2016 · Vol. 7, No. 24 · pp. 36474-36488
Tobias M. Gorges, Sabine Riethdorf, Oliver von Ahsen, Paulina Nastały, Katharina Röck, Marcel Boede, Sven Peine, Andra Kuske, Elke Schmid, Christoph Kneip, Frank König, Marion Rudolph, Klaus Pantel
Published Apr 26, 2016 · Vol. 7, No. 23 · pp. 34930-34941
